Max Topp, MD, Professor and Head of Hematology, University Hospital of Wuerzburg Germany, on the development of a new risk management plan to potentially reduce the toxicity of CAR-T cell therapy.
Reducing Toxicity of CAR-T Cel Therapy
Max Topp, MD, Professor and Head of Hematology, University Hospital of Wuerzburg Germany, on the development of a new risk management plan to potentially reduce the toxicity of CAR-T cell therapy.